Add-on·Healthcare/Pharma Services·May 8, 2026
Bioscript adds Triducive
Adds Triducive to Bioscript, giving the platform another operating asset under Bioscript's ownership and adding another asset to the relevant private-equity portfolio.
BuyerBioscript
TargetTriducive
SponsorSovereign
TypeAdd-on
IndustryHealthcare
Sub-sectorPharma Services
The transaction adds Triducive to Bioscript, giving the platform another operating company in its portfolio.
Bioscript, backed by Sovereign, acquired Triducive, a consultancy that helps pharmaceutical and life sciences companies gather and publish clinical opinion.
Triducive's expertise supports evidence-based decision-making for pharma clients seeking to strengthen their market positioning.
Daily PE deal brief
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.